Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-11

FDA Approved: VIGAMOX — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

FDA approved a supplemental application for VIGAMOX (moxifloxacin hydrochloride) filed by Harrow Eye, LLC. This represents a supplemental approval to the existi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIGAMOX (Moxifloxacin hydrochloride)

Snippet

SUPPL AP for VIGAMOX (MOXIFLOXACIN HYDROCHLORIDE)